3779 results for «2022»
3779 results
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options
22 Nov 2021 – From PCR London Valves
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.
HighLife TSMVR study status and new developments
22 Nov 2021 – From PCR London Valves 2021
Watch this session from the PCR London Valves 2021 Congress to find out more about HighLife systems and how it works, to witness a live recorded case presentation, to get clinical data, and to get an idea of the upcoming future alterations of the device to...
A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System
22 Nov 2021 – From PCR London Valves
Watch this session released during PCR London Valves 2021 Congress to have a deep dive into aortic regurgitation: the natural history, the clinical reality of it, and a fantastic live recorded case, so as to gain deeper understanding of the progression of severe aortic regurgitation, to learn more...
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
Intrepid early experience
23 Nov 2021 – From PCR London Valves 2021
This session of PCR London Valves 2021 needs to be watched to learn more about Medtronic's mitral and tricuspid clinical trial updates, better understand treatable anatomies for TMVR, and gain awareness on early feasibility Intrepid data.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
Practical solutions to grow your TAVI programme - peer-to-peer case sharing
23 Nov 2021 – From PCR London Valves 2021
Thanks to this PCR London Valves 2021 session, explore real-world examples of how to use digital communication successfully with your referral network, discover practical ways to implement a TAVI nurse programme in your hospital and learn how to obtain resources and support from your hospital management...
Procedural aspects of TAVI patient long-term management
22 Nov 2021 – From PCR London Valves 2021
At the PCR London Valves 2021 Congress, a session was proposed to discuss long-term management of TAVI patients: gain knowledge in procedural PCI access after TAVI through case examples, and learn more about the essential steps of the cusp overlap implantation technique by watching it now!
Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation
22 Nov 2021 – From PCR London Valves 2021
In this session broadcast at PCR London Valves 2021, discuss and explore transcatheter therapies for the treatment of tricuspid regurgitation and their clinical impact, analyze the recorded live case of an 81-year-old female patient from Leipzig, and discover the potential of transcatheter replacement technologies in the...
New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management
21 Nov 2021 – From PCR London Valves 2021
Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...
TAVI valve and implantation technique: the secrets for optimising outcomes
21 Nov 2021 – From PCR London Valves 2021
Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.
Closing TAVI with next generation suture mediated closure device
21 Nov 2021 – From PCR London Valves 2021
Join Francesco Maisano to learn more about about the Perclose ProStyle, a next generation closure device for TAVI procedures, and discover some interesting tips & tricks.
The science behind a valve designed for life
21 Nov 2021 – From PCR London Valves 2021
Join Christopher Meduri if you want to understand the features of a transcatheter heart valve that is designed to last the life of the patient, why a 3D single-piece aortic valve design can provide near normal pre-disease hemodynamics and how tissue science impacts leaflet preservation and...
